Anil Singhvi Market Strategy Today: Zee Business Managing Editor Anil Singhvi expects support for the Nifty50 index at 24,700-24,800 levels and a strong buy zone at 24,525-24,625 levels on Friday, September 26.
For the Nifty Bank, the market wizard expects support at 54,450-54,575 levels and a stronger support area at 54,200-54,400 levels.
How market guru Anil Singhvi sums up trade setup:
The market wizard expects a higher zone at 24,950-25,050 levels and a strong sell zone at 25,085-25,200 levels for the headline index.
For the banking index, he expects a higher zone at 55,150-55,275 levels and a strong sell zone at 55,350-55,500 levels.
How may Donald Trump’s latest announcements impact Dalal Street?
- A steep and sudden tariff on pharma is a big shock; around 6-7 per cent of US pharma imports come from India
- India’s share in US pharma imports is higher in volume but lower in value
- The reason is that India exports more generic medicines
- India accounts for 47 per cent of US generic pharma imports
- Trump has no issue with low-cost generic drugs; this is a positive outcome
- Generics save the US overall $400 billion
- Hence, the impact on Indian companies will be very limited
- But the issue is about negative sentiment
- After the H-1B visa issue, IT companies also said there was little impact
- Yet IT stocks remain weak even today
- Pharma stocks will also face the effect of poor sentiment
Which pharma stocks may fall and by how much?
- All stocks will be hit by negative sentiment
- Indian companies conduct businesses in the US directly or indirectly
- Two types of companies will be less affected:
- Those with plants in the US: Cipla, Dr Reddy’s Labs, Lupin, Syngene, Piramal Ph, IPCA Labs, Glenmark Pharma have plants in America
- Those with mostly generic exports: Aurobindo Ph, Cipla, Dr Reddy’s have majority generic business
- These three companies together hold a large share of the US generics market
- A big fall in these stocks could present a buying opportunity
ANIL SINGHVI MARKET STRATEGY | How to trade Nifty Bank and Nifty50?
For existing long positions:
-
Nifty intraday and closing stop loss at 24,800
-
Nifty Bank intraday and closing stop loss at 54,700
For existing short positions:
-
Nifty intraday and closing stop loss at 25,100
-
Nifty Bank intraday and closing stop loss at 55,350
For new positions in Nifty50:
-
Sell Nifty with a stop loss at 25,100 for targets of 24,800, 24,750, 24,700, 24,625, 24,575 and 24,525
-
Aggressive traders can buy Nifty in the 24,575-24,700 range with a strict stop loss at 24,500 for targets of 24,775, 24,800, 24,850, 24,875, 24,900 and 24,975
For new positions in Nifty Bank:
- Sell Nifty Bank with a stop loss at 55,300 for targets of 54,750, 54,700, 54,575, 54,525, 54,450, 54,400 and 54,300
- Aggressive traders can buy Nifty Bank in the 54,400-54,575 range with a strict stop loss at 54,200 for targets of 54,700, 54,825, 54,900, 54,975, 55,150 and 55,275
Stock in F&O ban
- Already in ban: Sammaan Capital, RBL Bank
- Out of ban: HFCL
- New in ban: None
